There is no universal “good” CAC payback period. There’s only a good payback period for your stage, your vertical, and your capital position, and most of the benchmark content online skips straight past that.
Why the Generic Benchmark Fails
The common advice floating around is that 12 months is a healthy CAC payback and anything beyond 18 months is a problem. That’s a reasonable default for a Series B SaaS company with a clear path to Series C. It’s a dangerous default for a Series A healthcare company still finding product-market fit, and it’s overly conservative for a Series C company with runway to burn for strategic land-grab reasons.
The number without the stage attached is close to meaningless.
Series A: Payback Matters Less Than Signal
At Series A, the priority is proving the growth model works at all, not optimizing payback efficiency. A 15-18 month payback is often fine here if the underlying signal is strong: conversion rates are stable, the ICP is validated, and the CAC trend is flat or improving as spend increases.
What actually matters more at this stage is whether payback is predictable. An 18-month payback you can forecast within a reasonable range is a better position than a 10-month payback that swings unpredictably month to month, because the second one means you don’t actually understand your growth model yet.
Series B: Payback Becomes the Efficiency Story
By Series B, investors expect to see payback tightening as the company scales, because at this stage the story shifts from “does this work” to “does this get more efficient with volume.” A payback period that’s flat or worsening as spend scales is one of the fastest ways to lose confidence in a Series B board meeting.
This is where vertical matters enormously. In healthcare and EdTech, longer consideration cycles mean a 12-15 month payback can still be healthy at Series B. In transactional B2C or lower-ACV B2B SaaS, anything past 12 months at this stage usually signals a structural CAC problem, not a market timing issue.
Series C and Beyond: Capital Efficiency Is the Whole Game
At Series C, payback period stops being a growth-model question and becomes a capital allocation question. A company with strong unit economics and ample runway might intentionally accept a longer payback to grab market share aggressively, using capital as a competitive weapon.
A company burning toward its next raise without a clear efficiency story cannot afford that same patience. The same 15-month payback number means something completely different depending on how much runway sits behind it.
The Vertical-Specific Nuance Most Benchmarks Miss
Payback expectations should also flex by vertical, not just stage. Healthcare and EdTech buying cycles run long by nature, often 60-120 days from first touch to close, which structurally extends payback regardless of marketing performance. Holding a healthcare company to a consumer SaaS payback benchmark punishes the business model, not the marketing team.
How I Actually Use This With Clients
Instead of chasing a generic benchmark, I build the payback target backward from three inputs: current funding stage and runway, sales cycle length by vertical, and whether the board’s near-term priority is proving the model or scaling the model. That produces a target that’s actually useful, instead of a number pulled from a blog post written for a different kind of company entirely.